Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWise Group Regulatory News (WISE)

Share Price Information for Wise Group (WISE)

Share Price is delayed by 15 minutes
Get Live Data
820.00    -6.00 (-0.73%)
Bid:
818.00
Ask:
822.00
Spread: 4.00 (0.489%)
Market Cap: £8.20b
WISE Live PriceLast checked at - London Stock Exchange

Intraday Wise Group Share Chart

FCA Investigation

27 Jun 2022 07:00

RNS Number : 2073Q
Wise PLC
27 June 2022
 

Wise plc

27 June 2022

 

This announcement contains inside information

 

Financial Conduct Authority (FCA) Investigation into Kristo Käärmann

 

In September 2021, HM Revenue & Customs ("HMRC"), the UK tax authority, updated its published list of individuals and businesses receiving penalties for a deliberate default regarding their tax affairs (the "list"). Co-founder and Chief Executive Officer of Wise, Kristo Käärmann ("Kristo" and the "CEO"), was included on the list and will remain so for 12 months from its publication.

 

Following the inclusion of the CEO's name in this list, the Board of Wise (the "Board") conducted an investigation with support from external legal counsel. The investigation concluded in Q4 2021, and the Board shared details of its findings, assessment and actions with the FCA.

 

In relation to this matter, the FCA has commenced an investigation regarding the regulatory obligations and standards to which Kristo is subject. Kristo intends to cooperate fully with the FCA in its investigation.

 

David Wells, Chair, said: "The Board takes Kristo's tax default and the FCA's investigation very seriously. After reviewing the matter late last year the Board required that Kristo take remedial actions, including appointing professional tax advisors to ensure his personal tax matters are appropriately managed. The Board has also shared details of its own findings, assessment and actions with the FCA and will cooperate fully with the FCA as and when they require, while continuing to support Kristo in his role as CEO."

 

At this time, Wise does not intend to make any further comment given the ongoing regulatory investigation. As and when appropriate, Wise will provide an update.

 

 

Enquiries

 

Martyn Adlam - Head of Owner Relations

martyn.adlam@wise.com

Sana Rahman - Head of Public Relations

press@wise.com

Brunswick Group

Charles Pretzlik / Sarah West / Samantha Chiene

Wise@brunswickgroup.com

+44 (0) 20 7404 5959

 

About Wise

Wise is a global technology company, building the best way to move money around the world. With the Wise account people and businesses can hold over 50 currencies, move money between countries and spend money abroad. Large companies and banks use Wise technology too; an entirely new cross-border payments network that will one day power money without borders for everyone, everywhere. However you use the platform, Wise is on a mission to make your life easier and save you money. Co-founded by Kristo Käärmann and Taavet Hinrikus, Wise launched in 2011 under its original name TransferWise.

It is one of the world's fastest growing profitable tech companies and is listed on the London Stock Exchange under the ticker, WISE. 13 million people and businesses use Wise, which processes over £8 billion in cross-border transactions every month, saving customers over £1 billion a year.

 

FORWARD LOOKING DISCLOSURE DISCLAIMER

This announcement may include forward-looking statements, which are based on current expectations and projections about future events. These statements may include, without limitation, any statements preceded by, followed by or including words such as "target", "believe", "expect", "aim", "intend", "may", "anticipate", "estimate", "plan", "project", "will", "can have", "likely", "should", "would", "could" and any other words and terms of similar meaning or the negative thereof. These forward-looking statements are subject to risks, uncertainties and assumptions about Wise and its subsidiaries. In light of these risks, uncertainties and assumptions, the events in the forward-looking statements may not occur. Past performance cannot be relied upon as a guide to future performance and should not be taken as a representation that trends or activities underlying past performance will continue in the future. No representation or warranty is made or will be made that any forward-looking statement will come to pass. The forward-looking statements in this announcement speak only as at the date of this announcement.

Wise expressly disclaims any obligation or undertaking to update, review or revise any forward-looking statements contained in this announcement and disclaims any obligation to update its view of any risks or uncertainties described herein or to publicly announce the results of any revisions to the forward-looking statements made in this announcement, whether as a result of new information, future developments or otherwise, except as required by law

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKQLFLLQLEBBF
Date   Source Headline
3rd Jun 20264:25 pmRNSHolding(s) in Company
2nd Jun 202611:44 amRNSTotal Voting Rights
1st Jun 20268:59 amRNSWise Europe
11th May 202611:00 amRNSWise debuts US listing on Nasdaq
11th May 20268:00 amRNSTotal Voting Rights
11th May 20268:00 amRNSCancellation - Wise plc
11th May 20267:00 amRNSScheme of Arrangement becomes effective
6th May 202612:43 pmRNSDirector/PDMR Shareholding
1st May 20261:55 pmRNSTotal Voting Rights
27th Apr 20263:33 pmRNSScheme of Arrangement
24th Apr 20261:07 pmRNSDirector/PDMR Shareholding
23rd Apr 20262:49 pmRNSTotal Voting Rights
22nd Apr 20263:13 pmRNSDirector/PDMR Shareholding
22nd Apr 20261:32 pmRNSHolding(s) in Company
16th Apr 20264:01 pmRNSDirector/PDMR Shareholding
13th Apr 20261:39 pmRNSPublication of a Prospectus
13th Apr 20267:53 amRNSQ4 FY2026 Trading Update
13th Apr 20267:01 amRNSTranslation of IFRS financials into US GAAP
13th Apr 20267:00 amRNSQ4 FY2026 Trading Update
9th Apr 20269:05 amRNSNotice of Q4 FY2026 Results
1st Apr 20262:50 pmRNSTotal Voting Rights
3rd Mar 202610:46 amRNSTotal Voting Rights
2nd Mar 20269:00 amRNSBoard Appointment
16th Feb 202610:43 amRNSChange of Adviser
4th Feb 202612:54 pmRNSHolding(s) in Company
2nd Feb 20264:13 pmRNSTotal Voting Rights
30th Jan 20263:43 pmRNSHolding(s) in Company
23rd Jan 202612:02 pmRNSDirector/PDMR Shareholding
20th Jan 20264:15 pmRNSDirector/PDMR Shareholding
20th Jan 20267:00 amRNSWise Q3 FY26 trading update
19th Jan 20263:12 pmRNSDirector/PDMR Shareholding
2nd Jan 20261:11 pmRNSTotal Voting Rights
3rd Dec 202512:53 pmRNSDirector/PDMR Shareholding
1st Dec 20252:57 pmRNSTotal Voting Rights
21st Nov 202512:35 pmRNSPublication of pricing supplements
18th Nov 20255:00 pmRNSDirector/PDMR Shareholding
13th Nov 20259:14 amRNSEstablishment of Euro Medium Term Note Programme
10th Nov 202510:28 amRNSDirector/PDMR Shareholding
7th Nov 20253:24 pmRNSDirector/PDMR Shareholding
6th Nov 20257:00 amRNSFY26 Half Year Results
3rd Nov 20254:35 pmRNSTotal Voting Rights
16th Oct 20255:20 pmRNSDirector/PDMR Shareholding
10th Oct 20251:46 pmRNSTotal Voting Rights
9th Oct 20252:52 pmRNSDirector/PDMR Shareholding
3rd Oct 20253:36 pmRNSDirector/PDMR Shareholding
25th Sep 20253:31 pmRNSResult of AGM
23rd Sep 20253:40 pmRNSHolding(s) in Company
23rd Sep 20252:03 pmRNSTotal Voting Rights
9th Sep 20255:56 pmRNSDirector/PDMR Shareholding
1st Sep 20252:13 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.